← All organizations

Q-Med AB

For profitWebsite ↗

Also known as: Q-Med AB

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Jan 31, 2022

Acquired by Galderma → Nestle on Jan 5, 2011

Timeline

1980s

Jan 1, 1987
Q-Med AB— Founded

2010s

Jan 5, 2011
Galderma— Acquired By
Feb 11, 2014
Nestle— Now

Drugs by trial phase (4 distinct, 15 trials)

Phase 4 (3 own, 0 via acquisition)

Phase 3 (1 own, 0 via acquisition)

onabotulinumtoxinA

Indications

Studied for

Recent trials (16)

NCT05148000Lead sponsorPhase 3Jan 31, 2022
NCT05146999Lead sponsorPhase 3Jan 15, 2022
NCT04249687Lead sponsorPhase 3Feb 29, 2020
NCT04247074Lead sponsorPhase 3Feb 29, 2020
NCT04249583Lead sponsorPhase 3Feb 29, 2020
NCT04225260Lead sponsorPhase 3Jan 13, 2020
NCT04080882Lead sponsorPhase 2Sep 30, 2019
NCT03960957Lead sponsorPhase 3Jun 30, 2019
NCT03736928Lead sponsorPhase 2Nov 26, 2018
NCT03687736Lead sponsorPhase 4Oct 31, 2018
NCT02297516Lead sponsorPhase 4Nov 1, 2014
NCT02297503Lead sponsorPhase 4Nov 1, 2014
NCT02236312Lead sponsorPhase 2Sep 1, 2014
NCT02108158Lead sponsorPhase 4Apr 1, 2014
NCT02139319Study directorPhase 1Mar 1, 2014

Details

Founded: Uppsala, CH Jan 1, 1987
Last known activity: Jan 31, 2022